ACRS
Aclaris Therapeutics Inc

4,945
Loading...
Loading...
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
64

Frequently Asked Questions

What is Market Cap of Aclaris Therapeutics Inc?
What is the 52-week high for Aclaris Therapeutics Inc?
What is the 52-week low for Aclaris Therapeutics Inc?
What is Aclaris Therapeutics Inc stock price today?
What was Aclaris Therapeutics Inc stock price yesterday?
What is the PE ratio of Aclaris Therapeutics Inc?
What is the Price-to-Book ratio of Aclaris Therapeutics Inc?
What is the 50-day moving average of Aclaris Therapeutics Inc?
How many employess does Aclaris Therapeutics Inc has?

Latest ACRS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.